Stay updated on STORM Clinical Trial - Selinexor in Refractory Myeloma
Sign up to get notified when there's something new on the STORM Clinical Trial - Selinexor in Refractory Myeloma page.

Latest updates to the STORM Clinical Trial - Selinexor in Refractory Myeloma page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.2.0 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check17 days agoChange DetectedRemoved the site-wide funding-status banner about government delays. This banner did not affect the study data or the history of this trial record.SummaryDifference0.4%

- Check32 days agoChange DetectedThe screenshots show updates to the record history (additional version entries and status notes) rather than substantive changes to core study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check60 days agoChange DetectedAdds a government-status notice and a new software version (v3.2.0); removes the old version tag (v3.1.0).SummaryDifference10%

- Check67 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.2%

- Check81 days agoChange DetectedThe page version updates from v3.0.1 to v3.0.2, and the 'Back to Top' element was removed; overall, this is a minor update with no impact on core content.SummaryDifference0.6%

Stay in the know with updates to STORM Clinical Trial - Selinexor in Refractory Myeloma
Enter your email address, and we'll notify you when there's something new on the STORM Clinical Trial - Selinexor in Refractory Myeloma page.